Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow-to-Debt Ratio
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-1.04 Million could theoretically repay 0% of its total liabilities (CN¥1.78 Billion) in one year. Check cash flow reinvestment rate of Wanbangde Pharmaceutical Holding Group C to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Wanbangde Pharmaceutical Holding Group Co Ltd across 23 annual periods. Also explore 002082 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. For market capitalisation and broader financial context, see market cap of Wanbangde Pharmaceutical Holding Group C.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥603.98 Million | CN¥1.78 Billion | ▲ +342.5% |
| 2024 | 0.08x | CN¥120.22 Million | CN¥1.57 Billion | ▲ +261.5% |
| 2023 | -0.05x | CN¥-72.87 Million | CN¥1.54 Billion | ▲ +72.4% |
| 2022 | -0.17x | CN¥-239.65 Million | CN¥1.40 Billion | ▼ -1364.0% |
| 2021 | 0.01x | CN¥22.09 Million | CN¥1.63 Billion | ▼ -74.8% |
| 2020 | 0.05x | CN¥151.01 Million | CN¥2.80 Billion | ▲ +140.9% |
| 2019 | -0.13x | CN¥-248.69 Million | CN¥1.89 Billion | ▼ -209.1% |
| 2018 | 0.12x | CN¥135.40 Million | CN¥1.12 Billion | ▲ +440.5% |
| 2017 | -0.04x | CN¥-17.60 Million | CN¥496.58 Million | ▼ -103.0% |
| 2016 | 1.19x | CN¥310.71 Million | CN¥261.85 Million | ▲ +1813.3% |
| 2015 | 0.06x | CN¥16.76 Million | CN¥270.28 Million | ▼ -88.7% |
| 2014 | 0.55x | CN¥140.31 Million | CN¥254.69 Million | ▼ -15.1% |
| 2013 | 0.65x | CN¥234.35 Million | CN¥361.07 Million | ▲ +50.2% |
| 2012 | 0.43x | CN¥202.73 Million | CN¥469.09 Million | ▲ +11897.2% |
| 2011 | 0.00x | CN¥-1.44 Million | CN¥392.22 Million | ▼ -100.9% |
| 2010 | 0.43x | CN¥162.26 Million | CN¥380.46 Million | ▲ +92.4% |
| 2009 | 0.22x | CN¥68.13 Million | CN¥307.39 Million | ▼ -72.9% |
| 2008 | 0.82x | CN¥253.06 Million | CN¥309.46 Million | ▲ +3265.4% |
| 2007 | 0.02x | CN¥12.45 Million | CN¥512.51 Million | ▲ +242.8% |
| 2006 | 0.01x | CN¥3.50 Million | CN¥493.85 Million | ▼ -67.9% |
| 2005 | 0.02x | CN¥11.23 Million | CN¥508.84 Million | ▼ -81.1% |
| 2004 | 0.12x | CN¥32.69 Million | CN¥280.48 Million | ▼ -48.7% |
| 2003 | 0.23x | CN¥37.01 Million | CN¥163.05 Million | — |